🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China flag China · Delayed Price · Currency is CNY
26.43
-1.44 (-5.17%)
Nov 20, 2026, 3:00 PM CST

SHA:603983 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3,2393,4552,9682,2251,7301,726
Other Revenue
4.74.72.040.661.960.68
3,2443,4592,9702,2261,7321,787
Revenue Growth
-6.46%16.48%33.44%28.52%-3.09%2.41%
Cost of Revenue
874.57892.81793.26665.27557.04654.5
Gross Profit
2,3692,5672,1771,5601,1751,133
Selling, General & Admin
2,1852,2171,7431,307957.43841.66
Research & Development
91.185.3773.5462.2952.9350.49
Other Operating Expenses
35.8532.9520.4717.8824.123.33
Operating Expenses
2,3112,3351,8371,3851,037916.19
Operating Income
58.1231.39339.26175.31137.59216.34
Interest Expense
-3.23-3.28-9.86-6.63-3.24-1.02
Interest & Investment Income
85.3649.2544.4465.0543.6460.14
Currency Exchange Gain (Loss)
0.040.04-0.010.020.061.74
Other Non Operating Income (Expenses)
-1.35-1.52-0.29-0.640.21-0.98
EBT Excluding Unusual Items
138.91275.87373.54233.12178.26276.22
Gain (Loss) on Sale of Investments
4.60.43-0.9870.985.290.61
Gain (Loss) on Sale of Assets
-0.260.12-0.290.450.280.42
Asset Writedown
-1.85-----0.1
Other Unusual Items
19.3119.318.3912.5322.7532.47
Pretax Income
160.71295.73380.66317.09206.58309.63
Income Tax Expense
15.2848.9938.2939.539.1568.43
Earnings From Continuing Operations
145.43246.74342.36277.59167.43241.19
Minority Interest in Earnings
-4.80.5-0.74-18.176.756.73
Net Income
140.63247.24341.63259.42174.18247.92
Net Income to Common
140.63247.24341.63259.42174.18247.92
Net Income Growth
-59.44%-27.63%31.69%48.93%-29.74%-46.62%
Shares Outstanding (Basic)
402399402399405400
Shares Outstanding (Diluted)
402399402399405400
Shares Change
-0.38%-0.78%0.70%-1.47%1.30%-0.12%
EPS (Basic)
0.350.620.850.650.430.62
EPS (Diluted)
0.350.620.850.650.430.62
EPS Growth
-59.28%-27.06%30.77%51.16%-30.64%-46.55%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-88.0368.63-15.8583.98-62.47-124.62
Free Cash Flow Per Share
-0.220.17-0.040.21-0.15-0.31
Dividend Per Share
0.2500.5000.7500.5200.2500.190
Dividend Growth
-66.67%-33.33%44.23%108.00%31.58%-45.71%
Gross Margin
73.04%74.19%73.29%70.11%67.83%63.38%
Operating Margin
1.79%6.69%11.42%7.88%7.95%12.11%
Profit Margin
4.33%7.15%11.50%11.66%10.06%13.87%
Free Cash Flow Margin
-2.71%1.98%-0.53%3.77%-3.61%-6.97%
EBITDA
142.56290.19363.85192.17154.13231.83
EBITDA Margin
4.40%8.39%12.25%8.63%8.90%12.97%
D&A For EBITDA
84.4658.824.5916.8616.5415.49
EBIT
58.1231.39339.26175.31137.59216.34
EBIT Margin
1.79%6.69%11.42%7.88%7.95%12.11%
Effective Tax Rate
9.51%16.56%10.06%12.46%18.95%22.10%
Revenue as Reported
3,2443,4592,9702,2261,7321,787
Advertising Expenses
-1,7211,354956.67656.1544.22